Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
暂无分享,去创建一个
B. Ludewig | S. Pagano | N. Vuilleumier | A. Rubbert-Roth | W. Albrich | J. Kempis | K. Schmiedeberg